Clinical trial for Veterans
Official title Varenicline for Smoking Reduction in Veterans Not Ready To Quit
ClinicalTrials.gov ID: NCT06966362
What this study is testing
What is Motivation-Phase Varenicline?
An investigational oral medication being studied as a potential treatment to help veterans who smoke and are not ready to quit. It is designed to act as a partial agonist at nicotine receptors in the brain, which may lessen cravings and withdrawal symptoms.
Also referred to as Chantix.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether a medicine called varenicline helps Veterans start quitting. It looks at how well it works for people not ready to stop smoking.
- Who it's for
- You may be able to join if you are a Veteran who smokes but is not ready to quit yet.
- What's involved
- You would take a medicine to help with smoking. You would also talk with a care team about your smoking habits.
- Time commitment
- The study lasts for a set time to see if you try to quit and stay smoke-free.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older
You may be able to join if
- Report smoking an average of 5 or more cigarettes daily for the previous 6 months
- Not ready to set a quit date in the next 30 days but willing to cut down on their smoking
- Able to read, write, and speak English
- Be medically eligible to use study medications (nicotine replacement therapy (NRT) or varenicline)
- If female, use an approved method of birth control while using study medication
You likely can't join if
- Unable to give informed, voluntary consent to participate
- Current use of any pharmacotherapy for smoking cessation
- Use of non-cigarette tobacco products as primary form of tobacco use
- Incarceration
See the full eligibility criteria
- Report smoking an average of 5 or more cigarettes daily for the previous 6 months
- Not ready to set a quit date in the next 30 days but willing to cut down on their smoking
- Able to read, write, and speak English
- Be medically eligible to use study medications (nicotine replacement therapy (NRT) or varenicline)
- If female, use an approved method of birth control while using study medication
- Be a Veteran
- Unable to give informed, voluntary consent to participate
- Current use of any pharmacotherapy for smoking cessation
- Use of non-cigarette tobacco products as primary form of tobacco use
- Incarceration
The study team makes the final eligibility decision.
Where it is enrolling
- San Diego, California, United States
- Minneapolis, Minnesota, United States
- Durham, North Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at San Diego, California, United States; Minneapolis, Minnesota, United States; Durham, North Carolina, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.